Log in with your email address username.


[Correspondence] Percutaneous coronary intervention for stable angina in ORBITA

We read the ORBITA trial1 by Rasha Al-Lamee and colleagues and commend all authors in their efforts to define the placebo effect of percutaneous coronary intervention (PCI) in stable angina compared with guideline-directed medial therapy (GDMT). However, we raise concerns about clinical translatability and urge caution regarding suggestions that ORBITA shows “unequivocally that there are no benefits for PCI compared with medical therapy for stable angina”.2